MedTech company focused on neurodegenerative diseases
REGEnLIFE has raised $3.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
REGEnLIFE is headquartered in Paris, France.
MedTech company focused on neurodegenerative diseases
REGEnLIFE is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"REGEnLIFE — Funding & Investors." VCBacked, May 12, 2023, https://www.vcbacked.co/company/regenlife. Accessed July 21, 2026.
VCBacked. (2023). REGEnLIFE — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/regenlife
{{cite web |title=REGEnLIFE — Funding & Investors |url=https://www.vcbacked.co/company/regenlife |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated